Published in Br Med J on July 06, 1974
"But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk. Br Med J (Clin Res Ed) (1982) 1.55
Purchasing for quality: the providers' view. Purchasing care for patients with acute myocardial infarction. Qual Health Care (1992) 1.34
Survey of general practitioners' attitudes to management of patients with heart attacks. Br Med J (1975) 1.26
Randomised multicentre trial of early mobilisation after uncomplicated myocardial infarction. Br Heart J (1979) 0.89
Exercise in cardiac rehabilitation. Br J Sports Med (1999) 0.84
Early identification of patients at low risk of death after myocardial infarction and potentially suitable for early hospital discharge. BMJ (1994) 0.83
Rapid mobilisation after acute myocardial infarction. First step in rehabilitation and secondary prevention. Br Heart J (1977) 0.80
Controlled trial of early mobilisation and discharge from hospital in uncomplicated myocardial infarction. Lancet (1971) 6.52
A new coronary prognostic index. Lancet (1969) 6.37
Venous thrombosis of the lower limbs with particular reference to bed-rest. Br J Surg (1957) 3.47
Frequency of venous thrombosis after myocardial infarction. Lancet (1971) 1.76
"Armchair" treatment of acute coronary thrombosis. J Am Med Assoc (1952) 1.51
Late ventricular dysrhythmias after myocardial infarction. Br Med J (1968) 1.45
St-segment displacement and early hospital discharge in acute myocardial infarction. Lancet (1973) 1.28
Early hospital discharge after myocardial infarction. N Engl J Med (1973) 1.18
Deep venous thrombosis after myocardial infarction. Predisposing factors. Br Heart J (1973) 1.11
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Early ambulation in myocardial infarction. Acta Med Scand (1970) 0.86
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol (1983) 10.23
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18
Isolation of the Legionnaires' disease bacterium from environmental samples. Ann Intern Med (1979) 7.69
Isolation of Legionella spp. from environmental water samples by low-pH treatment and use of a selective medium. J Clin Microbiol (1981) 6.88
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
The end of clinical freedom. Br Med J (Clin Res Ed) (1983) 6.27
Antistreptokinase titres after intravenous streptokinase. Lancet (1990) 4.77
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12
Legionella gormanii sp. nov. J Clin Microbiol (1980) 4.12
Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet (1988) 4.07
Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet (1988) 4.01
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet (1993) 3.43
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Audit of coronary angiography and bypass surgery. Lancet (1990) 3.17
Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation (2000) 2.90
Open access. BMJ (1995) 2.76
Comparison of results from a cardiac ambulance manned by medical or non-medical personnel. Lancet (1977) 2.75
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet (1990) 2.70
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Follow-up of emergency ambulance calls in Nottingham: implications for coronary ambulance servie. Br Med J (1975) 2.66
Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) (1986) 2.55
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53
Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46
Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J (1992) 2.46
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation (1993) 2.42
Use of Moore swabs for isolating Vibrio cholerae from sewage. J Clin Microbiol (1980) 2.36
Randomised trial of a mobile coronary care unit for emergency calls. Br Med J (1978) 2.35
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32
Prognosis of patients with "chest pain ?cause". Br Med J (Clin Res Ed) (1981) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Selective enrichment broth medium for isolation of Campylobacter jejuni. J Clin Microbiol (1983) 2.26
Isolation of Vibrio-like group, EF-6, from patients with diarrhea. J Clin Microbiol (1980) 2.20
A major focus of Legionnaires' disease in Bloomington, Indiana. Ann Intern Med (1979) 2.16
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Comparison of the Penner and Lior methods for serotyping Campylobacter spp. J Clin Microbiol (1985) 2.05
Mode of referral to hospital of patients with heart attacks: relevance to home care and special ambulance services. Br Med J (1976) 2.04
Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes (1978) 2.04
Comparison of four hippurate hydrolysis methods for identification of thermophilic Campylobacter spp. J Clin Microbiol (1985) 1.97
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Advanced training for ambulance crews: implications from 403 consecutive patients with cardiac arrest managed by crews with simple training. Br Med J (Clin Res Ed) (1987) 1.92
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90
Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation (1996) 1.86
Presentation and analysis of the results of clinical trials in cardiovascular disease. Br Med J (Clin Res Ed) (1981) 1.86
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Laboratory studies of disinfectants against Legionella pneumophila. Appl Environ Microbiol (1980) 1.83
Diagnostic criteria for myocardial infarction. Br J Hosp Med (1981) 1.82
Comparison of media for direct isolation and transport of Shigellae from Fecal specimens. Appl Microbiol (1970) 1.82
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol (1993) 1.80
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart (1999) 1.76
Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding. Br J Clin Pharmacol (1975) 1.76
Simple training programme for ambulance personnel in the management of cardiac arrest in the community. Br Med J (Clin Res Ed) (1985) 1.74
Bat predation and its influence on calling behavior in neotropical katydids. Science (1987) 1.71
Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis. Lancet (1983) 1.70
Neurological presentation of bacterial endocarditis. Br Med J (1967) 1.70
Differences in drug treatment of chronic heart failure between European countries. Eur Heart J (1999) 1.63
Evaluation of methods for isolating Salmonella and Arizona organisms from pet turtles. Appl Microbiol (1974) 1.62
The National Service Framework for coronary heart disease: the emperor's new clothes. J R Coll Physicians Lond (2000) 1.60
Comparison of mortality of patients with heart attacks admitted to a coronary care unit and an ordinary medical ward. Br Med J (1977) 1.57
Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55
Prevention and diagnosis of venous thrombosis in patients with hip fractures. A survey of current practice. Lancet (1976) 1.52
The health of the nation's research and development. BMJ (1993) 1.52
Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J (1979) 1.50
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Biochemical and genetic characteristics of atypical Campylobacter fetus subsp. fetus strains isolated from humans in the United States. J Clin Microbiol (1985) 1.49
Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register. QJM (1995) 1.47
Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteins. Br J Clin Pharmacol (1975) 1.46
Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors. J Nucl Cardiol (1998) 1.45
Influence of incubation temperature and sodium heptadecyl sulfate (Tergitol No. 7) on the isolation of salmonellae from pork sausage. Appl Microbiol (1970) 1.42
Comparison of four plating media for isolating Vibrio cholerae. J Clin Microbiol (1979) 1.41
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. Br Med J (1979) 1.41
Shigellosis in custodial institutions. Am J Epidemiol (1970) 1.40
Evaluation of thiosulfate-citrate-bile salts-sucrose agar, a selective medium for the isolation of Vibrio cholerae and other pathogenic vibrios. J Infect Dis (1974) 1.39
Infective endocarditis after transesophageal echocardiography. Circulation (1993) 1.39
The limited potential of special ambulance services in the management of cardiac arrest. Br Heart J (1990) 1.39
Captopril therapy for heart failure. A placebo controlled study. Lancet (1982) 1.39
Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy. Ann Intern Med (1980) 1.36
Cardiovascular control in diabetes mellitus. Br Med J (1975) 1.34
Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res (1967) 1.32
Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry (1976) 1.31
Abnormalities in platelet behaviour in acute illnesses. Br Med J (1966) 1.31
Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Br Med J (Clin Res Ed) (1986) 1.31
Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab (1985) 1.30
A study of the dissemination of salmonellosis in a commercial broiler chicken operation. Am J Vet Res (1969) 1.27
Nature of the transferable factor which causes abnormal platelet behaviour in vascular disease. Lancet (1967) 1.27
Cardiovascular reflex responses to apnoeic face immersion and mental stress in diabetic subjects. Cardiovasc Res (1976) 1.27
Clinical management of venous thrombo-embolism. Br Med Bull (1978) 1.26
Survey of general practitioners' attitudes to management of patients with heart attacks. Br Med J (1975) 1.26
Mycobacterium sp. as a possible cause of hypersensitivity pneumonitis in machine workers. Emerg Infect Dis (1999) 1.26
Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials. Br Med J (Clin Res Ed) (1982) 1.25
Diabetic autonomic neuropathy. Diabetes (1978) 1.25
Influence of ambulance crew's length of experience on the outcome of out-of-hospital cardiac arrest. Eur Heart J (1999) 1.24
Effect of oral contraceptive agents on platelets and plasma-phospholipids. Lancet (1968) 1.23